Memphis Pharmaceuticals (MPCI.CA) - Board of Directors' Decisions
Company Name : Memphis Pharmaceuticals
ISIN Code : EGS38351C010
Reuters Code : MPCI.CA
Content :
The Board of Directors' decisions held on 26/04/2022 concerning the unaudited financial results for the period ended 31/03/2022.
News Attachment I (248 KB)
News Attachment II (284 KB)
ISIN Code : EGS38351C010
Reuters Code : MPCI.CA
Content :
The Board of Directors' decisions held on 26/04/2022 concerning the unaudited financial results for the period ended 31/03/2022.
News Attachment I (248 KB)
News Attachment II (284 KB)
Comments